Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution.
Hedberg J, Studebaker A, Smith L, Chen CY, Westfall JJ, Cam M, Gross A, Hernandez-Aguirre I, Martin A, Kim D, Dhital R, Kim Y, Roberts RD, Cripe TP, Mardis ER, Cassady KA, Leonard J, Miller KE. Hedberg J, et al. Among authors: cassady ka. Mol Ther Oncolytics. 2023 Jul 19;30:39-55. doi: 10.1016/j.omto.2023.07.006. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37583388 Free PMC article.
Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously.
Luo W, Hoang H, Miller KE, Zhu H, Xu S, Mo X, Garfinkle EAR, Costello H, Wijeratne S, Chemnitz W, Gandhi R, Liao Y, Ayello J, Gardenswartz A, Rosenblum JM, Cassady KA, Mardis ER, Lee DA, Cripe TP, Cairo MS. Luo W, et al. Among authors: cassady ka. J Exp Clin Cancer Res. 2024 Jul 11;43(1):193. doi: 10.1186/s13046-024-03093-w. J Exp Clin Cancer Res. 2024. PMID: 38992659 Free PMC article.
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.
Paudel SN, Hutzen BJ, Miller KE, Garfinkle EAR, Chen CY, Wang PY, Glaspell AM, Currier MA, Ringwalt EM, Boon L, Mardis ER, Cairo MS, Ratner N, Dodd RD, Cassady KA, Cripe TP. Paudel SN, et al. Among authors: cassady ka. Front Immunol. 2024 Jul 9;15:1456897. doi: 10.3389/fimmu.2024.1456897. eCollection 2024. Front Immunol. 2024. PMID: 39044814 Free PMC article.
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors.
Paudel SN, Hutzen BJ, Miller KE, Garfinkle EAR, Chen CY, Wang PY, Glaspell AM, Currier MA, Ringwalt EM, Boon L, Mardis ER, Cairo MS, Ratner N, Dodd RD, Cassady KA, Cripe TP. Paudel SN, et al. Among authors: cassady ka. Front Immunol. 2024 Jun 25;15:1384623. doi: 10.3389/fimmu.2024.1384623. eCollection 2024. Front Immunol. 2024. PMID: 39044819 Free PMC article.
Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy.
Kim Y, Saini U, Kim D, Hernandez-Aguirre I, Hedberg J, Martin A, Mo X, Cripe TP, Markert J, Cassady KA, Dhital R. Kim Y, et al. Among authors: cassady ka. Front Immunol. 2024 Jun 4;15:1375413. doi: 10.3389/fimmu.2024.1375413. eCollection 2024. Front Immunol. 2024. PMID: 38895115 Free PMC article.
Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study.
Miller KE, Cassady KA, Roth JC, Clements J, Schieffer KM, Leraas K, Miller AR, Prasad N, Leavenworth JW, Aban IB, Whitley RJ, Gillespie GY, Mardis ER, Markert JM. Miller KE, et al. Among authors: cassady ka. Clin Cancer Res. 2022 Feb 1;28(3):498-506. doi: 10.1158/1078-0432.CCR-21-2636. Clin Cancer Res. 2022. PMID: 35105718 Free PMC article.
56 results